LEO Pharma appoints Leanne Walsh as general manager and vice president for UK and Ireland
June 19, 2023LEO Pharma, appointment, general manager, vice president
Medical dermatology company LEO Pharma has announced that it has appointed Leanne Walsh as its new general manager and vice …
Nordic Bioscience receives FDA Letter of Support for biomarker in aggressive tumour fibrosis
June 16, 2023Research and Development FDA, Nordic Bioscience, Oncology, Roche, tumour fibrosis
Danish biomarker company Nordic Bioscience has announced that the US Food and Drug Administration (FDA) has awarded it a Letter …
Takeda and HUTCHMEDโs cancer drug shown to prolong overall survival
June 16, 2023Research and Development HUTCHMED, Oncology, Takeda, colorectal cancer
Clinical trial data from a study into the metastatic colorectal cancer (CRC) drug fruquintinib, which is being developed by Japanese …
FDA gives Eagle Pharmaceuticals Qualified Infectious Disease Product (QIDP) and Fast-Track Designation for SCABP drug
June 15, 2023Research and Development Eagle Pharmaceuticals, FDA, FDA fast-track, Immunology, SCABP
US-based pharmaceutical company Eagle Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has granted its severe community-acquired …
Astellas and Cullgen enter into $1.9bn strategic collaboration to progress protein degraders
June 15, 2023Research and Development Astellas, Cullgen, Oncology, protein degraders
Japanese pharmaceutical company Astellas and US-based clinical-stage biopharmaceutical company Cullgen have announced that they have entered into a strategic research …
Critical Path Institute receives FDA Biomarker LOS for DIPI biomarkers
June 14, 2023Research and Development Critical Path Institute, Endocrinology, FDA, biomarkers, pancreatic injury
US-based Critical Path Institute (C-Path) has announced that the Biomarker Qualification Program (BQP) at the Center for Drug Evaluation and …
Kymera Therapeutics reports positive data in cancer drug trials
June 14, 2023Research and Development Cancer, Kymera Therapeutics, Oncology, autoimmune diseases, clinical trials, inflammatory diseases
US clinical-stage biopharmaceutical company Kymera Therapeutics has shared newย data regarding its oncology programmes KT-333 and KT-413, highlighting their robust dose-dependent …
AstraZenecaโs breast cancer drug given Priority Review by FDA
June 13, 2023Business Services AstraZeneca, FDA, Oncology, breast cancer
UK-based pharmaceutical company AstraZeneca has announced that the US Food and Drug Administration (FDA) has accepted its New Drug Application …
Novo Nordisk invests DKKย 15.9bn to expand API production in Denmark
June 13, 2023Manufacturing and Production APIs, Chronic Diseases, Novo Nordisk, chronic diseases
Danish healthcare company Novo Nordisk has announced that it will invest another DKK 15.9bn into expanding an existing Active Pharmaceutical …
PharmAla receives MDMA research grant from Ontario Centre of Innovation
June 12, 2023Research and Development MDMA, PharmAla, Psychiatry, in silico, research grant
Canadian biotechnology company PharmAla has announced that it has been awarded a research grant from the Ontario Centre of Innovation …
Novartis acquires Chinook Therapeutics for $3.5bn
June 12, 2023Mergers and Acquisitions Chinook Therapeutics, Nephrology, Novartis, kidney disease, pharma
Swiss pharmaceutical company Novartis has entered into an agreement and plan of merger with US-based biopharmaceutical company Chinook Therapeutics for …
AstraZeneca and MSDโs Lynparza receives NICE positive recommendation as a cancer maintenance treatment
June 9, 2023Research and Development AstraZeneca, Cancer, MSD, NICE, Oncology, lynparza, pharma
UK-based pharmaceutical company AstraZeneca has announced that the National Institute for Health and Care Excellence (NICE) posted a positive recommendation …
Astellas Pharma and BMT CTN announce phase 3 data for gilteritinib
June 9, 2023Research and Development Astellas Pharma, BMT CTN, Haematology, gilteritinib, leukaemia, pharmaceutical
Japanese pharmaceutical company Astellas Pharma and the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) have presented their phase …
Innate Pharma announces drug researched with Sanofi receives FDA Fast Track Designation
June 8, 2023Research and Development Cancer, FDA, Haematology, Innate Pharma, Sanofi, haematology
Innate Pharma has announcedย that the drug jointly researched between itself and Sanofi has received US Food and Drug Administration (FDA) …
Inventiva and Echosens collaborate to bring awareness to NASH and encourage screening for at-risk patients
June 8, 2023Medical Education Echosens, Hepatology, Inventiva, liver disease, nash, non-alcoholic steatohepatitis
French clinical stage biopharmaceutical company Inventiva has announced a collaboration with US-based high-technology company Echosens to bring attention to, and …
Inizio launches strategic engagement offering to transform customer experiences
June 7, 2023Business Services Inizio, Inizio Engage, commercialisation
6 June 2023 โ London, UK — Inizio, a global commercialisation partner dedicated to the health and life sciences industry, …
Fosun Pharma and IFC partner to improve access to medicines in Africa
June 7, 2023Manufacturing and Production Africa, Fosun Pharma, IFC, Infections and infestations, manufacturing
Shanghai Fosun Pharmaceutical Group has announced a partnership with the International Finance Corporation (IFC) with the aim of helping the …
GSKโs RSV vaccine approved in EU for older adults
June 7, 2023Medical Communications EU, GSK, Infections and infestations, RSV, Vaccine
GSK has announced that the European Commission (EC) has authorised Arexvy, the companyโs respiratory syncytial virus (RSV) vaccine for active …
Axol Bioscience and StrataStem collaborate to deliver โclinical trial in a dishโ for Alzheimerโs disease
June 7, 2023Research and Development Alzheimer's, Axol Bioscience, Neurology, StrataStem
Pluripotent stem cell technology provider Axol Bioscience has signed an exclusive agreement with UK-based StrataStem to access and commercialise its …
UK plans ยฃ40m drug trial for Novo Nordiskโs Wegovy to aid NHS in treating obesity
June 7, 2023Research and Development NHS, Novo Nordisk, Obesity, Wegovy, clinical trial, obesity
The UK Government has announced plans to launch a pilot programme which will provide GPs with Novo Nordiskโs Wegovy (semaglutide), …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
